Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
A clinician-reviewed guide to tadalafil pharmacokinetics, pharmacogenomics, and dose-adjustment considerations for Black and African ancestry men with ED, BPH, or PAH, with data from ethnicity-stratified trials and PharmGKB.
Read clinical reviewEvidence-based review of how Cialis (tadalafil) performs in Hispanic and Latino populations, including pharmacogenomic factors, diabetes-related considerations, and dosing guidance.
Read clinical reviewEvidence-based review of how tadalafil pharmacokinetics, dosing, and adverse-event rates differ in East Asian populations, including CYP3A4 metabolism data, Japanese regulatory decisions, and practical prescribing guidance.
Read clinical reviewHow South Asian genetics, cardiovascular risk factors, and metabolic patterns affect tadalafil (Cialis) safety, dosing, and monitoring. Evidence-based guidance with pharmacogenomic context.
Read clinical reviewA clinician-reviewed analysis of how tadalafil (Cialis) performs in Hispanic and Latino patients, covering pharmacogenomics, CYP3A4/5 variation, diabetes-related ED risk, blood pressure interactions, and ethnicity-stratified dosing guidance.
Read clinical reviewA clinician-reviewed guide to tadalafil dosing in South Asian patients, covering CYP3A4 and CYP2C9 variants, cardiovascular risk at lower BMI, drug interactions with metformin and statins, and evidence-based dose adjustment protocols.
Read clinical review